Cefminox sodium alleviates the high-fat high-sugar-fed mice's hepatic fatty accumulation via multiple pathways

The increasing global prevalence of nonalcoholic fatty liver disease (NAFLD) starves for effective therapy, but no agent has been approved yet. We sought to evaluate the therapy of cefminox sodium (CMNX) on fatty accumulation in animal and cell models and explore the underlying mechanisms. The resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Leming, Liang, Chengrui, Gao, Jing, Wang, Yin, Guo, Yanzi, Chen, Kan, Jia, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658294/
https://www.ncbi.nlm.nih.gov/pubmed/38027801
http://dx.doi.org/10.1016/j.heliyon.2023.e21973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658294/
https://www.ncbi.nlm.nih.gov/pubmed/38027801
http://dx.doi.org/10.1016/j.heliyon.2023.e21973

Ejemplares similares